Ashland has opened a pharmaceutical excipients plant in Nanjing, China in a bid to capture growing local demand for modern formulation technologies.
The US FDA has placed a Phase III trial of Inovio’s candidate DNA cancer vaccine VGX-3100 on clinical hold over concerns about its delivery device.
Patheon will make a candidate AMD treatment under a contract with French biotech Biophytis.
Everstone Capital has acquired a 70% stake in drug delivery tech firm Rubicon Research Pvt for $33m (€30m).
APIs made by Laxachem Organics pvt ltd were not the source of bacteria in Pharmatech laxatives linked to a spate of Burkholderia cepacia infections according to the US FDA.
Lannett is confident it can prove the extended release tech in its Concerta generic is equivalent to the original after the US FDA said it will seek withdrawal of firms ANDA.
Biotrial has accused French newspaper Le Figaro of leading a “smear campaign” through its coverage of the Phase I trial in which one man died and five others were hospitalised in January.
The US FDA has warned Teva Pharmaceutical Industries about its facility in Godollo, Hungary over ongoing concerns about manufacturing operations.